Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China · Delayed Price · Currency is CNY 10.65
-0.19 (-1.75%)
Sep 10, 2026, 1:14 PM CST
SHA:603998 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,870 | 1,746 | 1,777 | 1,629 | 1,792 | 1,567 |
Revenue Growth | 9.90% | -1.75% | 9.15% | -9.12% | 14.36% | 22.54% |
Gross Profit Gross Profit Growth | 1,390 | 1,250 | 1,260 | 1,106 | 1,203 | 1,001 |
Operating Income Operating Income Growth | 350.51 | 304.61 | 247.14 | 163.31 | 153.98 | 123.37 |
Net Income Net Income Growth | 334.81 | 306.39 | 255.22 | 186.82 | 285.85 | 70.04 |
Earnings Per Share EPS Growth | 0.76 | 0.70 | 0.58 | 0.42 | 0.66 | 0.16 |
EPS Growth | 17.16% | 20.69% | 38.09% | -36.36% | 312.50% | 6.67% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical Manufacturing Business Pharmaceutical Manufacturing Business Growth | 1,648 |
Intersegment Offset Intersegment Offset Growth | -47.83 |
Other Other Growth | 88.41 |
Total Total Growth | 1,689 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 307.67 | 276.25 | 308.46 | 229.3 | 440.03 | 274.3 |
Total Debt Total Debt Growth | 326.8 | 432.03 | 700.15 | 681.93 | 594.3 | 552.05 |
Net Cash (Debt) Net Cash Growth | -19.13 | -155.78 | -391.69 | -452.62 | -154.26 | -277.75 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.04 | -0.36 | -0.89 | -1.02 | -0.36 | -0.63 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 525.01 | 384.63 | 194.95 | 87.54 | 301.63 | 185.63 |
Capital Expenditures CapEx Growth | -92.91 | -102.52 | -94.79 | -218.78 | -171.25 | -184.71 |
Free Cash Flow Free Cash Flow Growth | 432.1 | 282.12 | 100.16 | -131.24 | 130.38 | 0.92 |
Free Cash Flow Growth | 142.99% | 181.67% | - | - | 14138.22% | -98.67% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 74.31% | 71.56% | 70.91% | 67.93% | 67.12% | 63.86% |
Operating Margin | 18.75% | 17.44% | 13.90% | 10.03% | 8.59% | 7.87% |
Pretax Margin | 21.39% | 20.23% | 16.09% | 12.49% | 18.22% | 5.79% |
Profit Margin | 17.90% | 17.54% | 14.36% | 11.47% | 15.95% | 4.47% |
FCF Margin | 23.11% | 16.15% | 5.63% | -8.06% | 7.28% | 0.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.300 | 0.250 | 0.290 | 0.350 | 0.150 |
Dividend Per Share Growth | 21.95% | 20.00% | -13.79% | -17.14% | 133.33% | 25.00% |
Dividend Yield | 4.61% | 2.74% | 2.56% | 2.89% | 4.92% | 2.58% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.26 | 16.11 | 17.93 | 25.80 | 12.32 | 41.69 |
Forward PE | 13.06 | 15.04 | 16.49 | 24.91 | 63.00 | 63.00 |
P/FCF Ratio | 11.02 | 17.49 | 45.69 | - | 27.01 | 3188.95 |
PS Ratio | 2.55 | 2.83 | 2.57 | 2.96 | 1.97 | 1.86 |